Total Funding
$1.1B
Employee Range
11-50
HAYA Therapeutics is a developer of RNA-based therapeutics created to treat heart failure. The company's therapeutics utilizes biopharmaceutical therapy to target a heart specific regulator of fibrosis, the long noncoding RNA, enabling physicians to to block myocardial fibrosis and treat heart failure.
HAYA Therapeutics data powered by:
Share
HAYA Therapeutics data powered by:
HAYA TherapeuticsOverall Ranking
National Rank
Share
Loading...
In Switzerland
Top null%out of startups
Regional Rank
Share
Loading...
In Western Europe
Top null%out of startups
HAYA TherapeuticsIndustry Rankings in
Healthtech
City Rank
Share
2nd
In Lausanne
Top 5%out of 42 startups
National Rank
Share
4th
In Switzerland
Top 2%out of 356 startups
Regional Rank
Share
75th
In Western Europe
Top 2%out of 4549 startups
HAYA TherapeuticsSubindustry Rankings in
BiotechnologyCity Rank
Share
2nd
In Lausanne
Top 11%out of 19 startups
National Rank
Share
3rd
In Switzerland
Top 2%out of 169 startups
Regional Rank
Share
6th
In Western Europe
Top 1%out of 1726 startups
rankings by:
HAYA TherapeuticsSB Rank Evolution
Not enough data points to display the chart.
HAYA TherapeuticsstartupComparison
National Ranking (undefined)
Loading...
...
Regional Ranking (undefined)
Loading...
...
Global Ranking (WorldWide)
Loading...
...
Industry Ranking (undefined)
Loading...
...
SubIndustry Ranking (undefined)
Loading...
...
See all ranked entities with a premium subscription
Get Pro